Expertise in
10
conditions

Dr. Bruce C. Corser

Internal Medicine | Pulmonary Medicine
8250 Kenwood Crossing Way, Suite 225, 
Cincinnati, OH 
On Staff At
Offers Telehealth
Expertise in
10
conditions
8250 Kenwood Crossing Way, Suite 225, 
Cincinnati, OH 

Overview

Bruce Corser is an Internal Medicine specialist and a Pulmonary Medicine provider in Cincinnati, Ohio. Dr. Corser is highly rated in 10 conditions, according to our data. His top areas of expertise are Narcolepsy, Drowsiness, Obstructive Sleep Apnea, and Excessive Daytime Sleepiness.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

State University Of New York At Syracuse, 1980

Residency

University Of Cincinnati, Internal Medicine, 1983

Specialties

Internal Medicine
Pulmonary Medicine

Licenses

Sleep Medicine in OH

Board Certifications

American Board Of Internal Medicine

Fellowships

University Of Cincinnati, Internal Medicine, 1987

Hospital Affiliations

The Jewish Hospital - Mercy Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Your MD, LLC
8250 Kenwood Crossing Way, Suite 225, Cincinnati, OH 45236

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Enrollment Status: Unknown
Publish Date: June 19, 2025
Intervention Type: Other, Device
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
ImThera Medical Targeted Hypoglossal Neurostimulation Study #3
ImThera Medical Targeted Hypoglossal Neurostimulation Study #3
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Device
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
View 10 Less Clinical Trials

9 Total Publications

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
Journal: Sleep medicine: X
Published: May 23, 2024
Similar Doctors
Expertise in
11
conditions
Dr. Robert Baughman
Pulmonary Medicine
Expertise in
11
conditions
Dr. Robert Baughman
Pulmonary Medicine

Thoma & Sutton EyeCare Professionals LLC

222 Piedmont Ave, 
Cincinnati, OH 
 (12.4 miles away)
513-584-5225
Languages Spoken:
English
See accepted insurances

Robert Baughman is a Pulmonary Medicine provider in Cincinnati, Ohio. Dr. Baughman is highly rated in 11 conditions, according to our data. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Interstitial Lung Disease, Endoscopy, and Lung Transplant.

Expertise in
10
conditions
Dr. Jean M. Elwing
Pulmonary Medicine | Intensive Care Medicine
Expertise in
10
conditions
Dr. Jean M. Elwing
Pulmonary Medicine | Intensive Care Medicine

University Of Cincinnati Physicians Company LLC

68 Cavalier Blvd, 
Florence, KY 
 (20.1 miles away)
513-475-7630
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jean Elwing is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Florence, Kentucky. Dr. Elwing is highly rated in 10 conditions, according to our data. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Systemic Sclerosis (SSc), and Embolectomy. Dr. Elwing is currently accepting new patients.

Expertise in
14
conditions
Dr. Narong Simakajornboon
Pediatric Pulmonology | Pulmonary Medicine | Pediatrics
Expertise in
14
conditions
Dr. Narong Simakajornboon
Pediatric Pulmonology | Pulmonary Medicine | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (12.3 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Narong Simakajornboon is a Pediatric Pulmonologist and a Pulmonary Medicine provider in Cincinnati, Ohio. Dr. Simakajornboon is highly rated in 14 conditions, according to our data. His top areas of expertise are Laryngomalacia, Central Sleep Apnea, Obstructive Sleep Apnea, Infantile Apnea, and Adenoidectomy. Dr. Simakajornboon is currently accepting new patients.

Frequently Asked Questions about Dr. Bruce C. Corser

How do I make an appointment with Dr. Bruce C. Corser?

You can book an appointment with Dr. Bruce C. Corser by calling their office at 513-721-9600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bruce C. Corser a top-rated expert for Narcolepsy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bruce C. Corser is classified as an Elite expert for Narcolepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bruce C. Corser specialize in?

While Dr. Bruce C. Corser is a Internal Medicine, they have specific expertise in Narcolepsy, Drowsiness, and Obstructive Sleep Apnea. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Bruce C. Corser participate in research or clinical trials?

Yes. Dr. Bruce C. Corser has published 9 articles and abstracts on conditions like Narcolepsy. You can view a list of Dr. Bruce C. Corser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Bruce C. Corser accept my insurance?

Dr. Bruce C. Corser accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 513-721-9600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Corser's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile